Nevertheless, in up to 20% of patients with the clinical diagnosis of CAIS and ruled out mutations in the steroid 5α-reductase type 2 gene (SRD5A2 gene), the molecular cause remains unknown [45]. Here, SRD5A2 is linked to complete androgen insensitivity syndrome.